Estimated reading time: 3 minute(s)
Overall, the increase in U.S. drug spend slowed in 2015.
Specialized care was reinvented.
Thirty seven percent of drug spend in 2015 was for speciality medications (prescriptions for patients with chronic or rare conditions). That number is expected to rise to 50% by 2018. To battle this upward trend, Express Scripts is using a number of innovative solutions, including paving the way for the use of biosimilars for specialty medications. Express Scripts National Preferred Formulary—the most widely used list of prescription drug coverage guidelines in the United States—has focused on prompting doctors to switch to these effective and more affordable solutions, already generating savings of $3 billion since 2014.